25 reports

It also offers products to treat gastrointestinal disorders, neurodegenerative pathologies and rheumatology diseases.

  • Dermatological Condition
  • Healthcare
  • Pathology
  • Pharmaceutical
  • Canada
  • JAN 26, 2018: HEMISPHERX ANNOUNCES PRESENTATION ON THE POTENTIAL ROLE OF AMPLIGEN AS AN IMMUNE SYSTEM AMPLIFIER IMPROVING SEASONAL FLU VACCINE CROSS-PROTECTION

The molecules developed by companies in Filing rejected/ Withdrawn, Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Pathology
  • Pharmaceutical
  • Canada
  • Product Initiative
  • Hemispherx Biopharma, Inc.
  • PARTNERSHIPS

Pursuant to the offering, each unit consists of one common share and one-half of one share purchase warrant.

  • Dementia
  • Pathology
  • Canada
  • Company
  • ProMIS Neurosciences Inc.

The company offers research and development; and clinical trial programs based on medicinal chemistry and detection and inhibition of proteases involved in human physiology and pathology.

  • Pathology
  • Therapy
  • Canada
  • Product Initiative
  • Novartis AG

Pursuant to the offering, each unit consists of one common share and one-half of one share purchase warrant.

  • Dementia
  • Pathology
  • Canada
  • Company
  • ProMIS Neurosciences Inc.

The molecules developed by companies in Phase II, Phase I, IND/ CTA Filed, Preclinical and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Pathology
  • Psychotic Disorder
  • Therapy
  • Canada
  • Protalix BioTherapeutics, Inc.
  • LICENSING AGREEMENTS

The compounds were developed by Gavin Robertson, professor of pharmacology, pathology, dermatology and surgery at Penn State University, and director of the Penn State Hershey Melanoma Center.

  • Pathology
  • Pharmaceutical
  • Canada
  • Company
  • Cipher

It carries out research and development; and clinical trial programs based on medicinal chemistry and detection and inhibition of proteases in human physiology and pathology.

  • Cancer
  • Pathology
  • Pharmaceutical
  • Therapy
  • Canada
  • Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) - Product Development Milestones

Ansari is a professor of pathology and laboratory medicine in the Department of Oct ##, 2016: Scientists at NIH and Emory achieve sustained SIV remission in monkeys Pathology and Laboratory Medicine at Emory University School of Medicine and a research associate at Emory' s Yer

  • Pathology
  • Targeted Therapy
  • Canada
  • Product Initiative
  • Takeda Pharmaceutical Company Limited

Each unit is consists of one common share and one-half of one share purchase warrant.

  • Medical Device
  • Medical Equipment
  • Pathology
  • Canada
  • Company

Bostwick' s offers subspecicalty laboratory services including dermatopathology, gastrointestinal pathology, gynecologic pathology, hematopathology, renal pathology, culture and susceptibility testing, molecular testing, and uroregistry, among others.

  • Cancer
  • Genomics
  • Pathology
  • Prostate Cancer
  • Canada

Each unit consists of one common share and one half of one common share purchase warrant.

  • Healthcare
  • Pathology
  • Pharmaceutical
  • Therapy
  • Canada
  • JAN 30, 2018: ENZYME INHIBITOR COMBINED WITH CHEMOTHERAPY DELAYS GLIOBLASTOMA GROWTH

Hackney, M. D., UAB Department of Pathology; Paul C.

  • Brain Cancer
  • Pathology
  • Pharmaceutical
  • Therapy
  • Canada

Each unit consists of one common share and one half of one common share purchase warrant.

  • Healthcare
  • Pathology
  • Pharmaceutical
  • Therapy
  • Canada

The company offers research and development; and clinical trial programs based on medicinal chemistry and detection and inhibition of proteases involved in human physiology and pathology.

  • Analgesic
  • Cancer
  • Pathology
  • Pharmaceutical
  • Canada
  • 05/23/2017: Qu Biologics Publishes Proof-of-Principle Data for Promising New Treatment for Chronic Obstructive Pulmonary Disease

The addition of these pioneering scientists will accelerate the broader application of the company' s cutting-edge approach for the treatment of immune pathologies.

  • Pathology
  • Pharmaceutical
  • Canada
  • Company
  • Qu Biologics Inc.

One unit equals to one test.

  • Medical Device
  • Pathology
  • Canada
  • Forecast
  • SQI Diagnostics Inc.

It offers research in the areas of cancer biomarker research, pathology IHC, stem cell research, ion channels, protein kinase, and others.

  • Chronic Disease
  • Medical Device
  • Pathology
  • Canada
  • Deals & Alliance

THE MOLECULES DEVELOPED BY COMPANIES IN PHASE III, PHASE II, PHASE I AND PRECLINICAL STAGES ARE ##, ##, ## AND ## RESPECTIVELY.

  • Heart Failure
  • Hospital
  • Pathology
  • Therapy
  • Canada

ONE UNIT REFERS TO ONE ML.

  • In Vitro Diagnostic Reagent
  • Infectious Disease
  • Pathology
  • Canada
  • North America
  • Jan 25, 2018: London researchers net over $8.6 million in CIHR funding

Koropatnick, a scientist at Lawson and professor in the Departments of Oncology, Microbiology and Immunology, Physiology and Pharmacology, and Pathology at Schulich School of Medicine & Dentistry, Western University.

  • Healthcare
  • Pathology
  • Canada
  • Company
  • Deals & Alliance
  • Jan 25, 2018: London researchers net over $8.6 million in CIHR funding

Koropatnick, a scientist at Lawson and professor in the Departments of Oncology, Microbiology and Immunology, Physiology and Pharmacology, and Pathology at Schulich School of Medicine & Dentistry, Western University.

  • Healthcare
  • Pathology
  • Psychotic Disorder
  • Therapy
  • Canada

Presently at the University of British Columbia: ##.

  • Healthcare
  • Pathology
  • Therapy
  • Canada
  • Deals & Alliance

It provides an alternative to prescription drugs for people suffering from pathologies that affect their quality of life.

  • Healthcare
  • Pathology
  • Pharmaceutical
  • Therapy
  • Canada
  • Industry

PARTNER ##: VERISANTE TECHNOLOGY, INC.

  • Cancer
  • Pathology
  • Pharmaceutical
  • Canada
  • Company